WHO flags a silent crisis: Are we running out of antibiotics that work?

The WHO's latest data show bacteria are evolving rapidly, outsmarting modern drugs, with South Asia and West Asia among the worst-hit regions as antibiotic resistance soars

antibiotic resistance, antimicrobial resistance
The WHO says one in six bacterial infections is now resistant to standard treatment due to overuse of antibiotics. (Photo: AdobeStock)
Barkha Mathur New Delhi
4 min read Last Updated : Oct 14 2025 | 12:07 PM IST
One in six bacterial infections worldwide is now resistant to antibiotic treatment and cannot be treated using standard medicines, the World Health Organization (WHO) has warned in its latest Global Antibiotic Resistance Surveillance Report 2025.
 
According to the WHO, between 2016 and 2023, resistance to life-saving drugs increased in over 40 per cent of the samples analysed across more than 100 countries, signalling a dangerous rise of “superbugs” that could make once-curable infections deadly again. The finding raises a troubling question: Are we fast approaching a post-antibiotic era where common infections no longer respond to medicine?

What is antibiotic resistance?

Antibiotic drugs are used to neutralise and treat bacterial infections. But bacteria adapt and evolve new tricks to survive these drugs. This phenomenon, known as antimicrobial resistance (AMR), turns once-curable infections into stubborn, sometimes deadly diseases.
 
Globally, AMR is already responsible for over one million deaths every year, according to WHO. The global health body has warned that “antimicrobial resistance is outpacing advances in modern medicine,” threatening everything from routine surgeries to cancer care. Without effective antibiotics, even a minor cut could spiral into a life-threatening infection.

How bad is the situation right now?

According to the report, antibiotic resistance levels are highest in South Asia and West Asia, where one in three infections no longer responds to standard treatments. In Africa, resistance to key antibiotics used for bloodstream infections exceeds 70 per cent.
 
Globally, Escherichia coli (E coli) and Klebsiella pneumoniae, two common culprits behind hospital infections, are becoming resistant to third-generation cephalosporins, the go-to antibiotics for severe cases. More than 40 per cent of E coli and 55 per cent of Klebsiella pneumoniae are now resistant. These are infections that can lead to sepsis, organ failure, and death.
 
The report further stated that even the last lines of defence, like carbapenems, often called “reserve antibiotics,” are losing their edge. Resistance is rising fastest among Gram-negative bacteria, the toughest of the microbial lot.

Why is antibiotic resistance rising so fast?

The report highlighted that it is not nature alone that is to blame, humans are fuelling this crisis. From popping antibiotics for viral fevers (where they do nothing) to farmers using them to make livestock grow faster, overuse and misuse are driving resistance across human, animal, and environmental ecosystems.
 
This is what the WHO calls the ‘One Health’ crisis, linking hospitals, farms, and food systems. According to the WHO, the more we misuse antibiotics, the cleverer bacteria become. In places with poor sanitation, lack of diagnostics, and limited access to quality healthcare, resistant bacteria thrive and spread unchecked.

Which infections are most at risk of becoming untreatable?

Urinary and gastrointestinal tract infections top the list, as nearly one in three now resists treatment. Bloodstream infections follow closely behind. Gonorrhoea, a once easily treatable sexually transmitted infection, is also making a dangerous comeback, 75 per cent of gonorrhoea samples are resistant to ciprofloxacin, a common antibiotic.
 
While some life-saving antibiotics like ceftriaxone still work, even the smallest rise in resistance could collapse our ability to treat these infections.

What makes this threat worse in countries like India?

India sits in one of the epicentres of antibiotic resistance, the WHO report shows. South-East Asia records some of the highest resistance levels in the world. Countries with weaker health systems, limited diagnostic labs, patchy surveillance, and easy antibiotic access without prescription face a double burden.
 
The WHO found that countries with lower health coverage had higher resistance rates.
 
WHO, however, indicated that there is a chance to reverse this trend as global surveillance is improving. Over 100 countries now report antibiotic resistance data through WHO’s GLASS platform, which has seen a four-fold rise since 2016. This helps scientists and policymakers track which antibiotics are losing power and where.
 
Yet, nearly half the world still lacks reliable surveillance data, meaning we might be underestimating the real scale of resistance.

Can we still prevent this 'post-antibiotic' future?

Yes, and for this, WHO is urging countries to:
  • Use antibiotics only when prescribed by qualified professionals
  • Invest in diagnostic labs to ensure the right antibiotic is used for the right infection
  • Strengthen infection control, vaccination, and sanitation systems
  • Ensure at least 70 per cent of antibiotic use globally comes from the WHO’s AWaRe (Access, Watch, Reserve)Access group by 2030
As WHO’s Director-General Dr Tedros Adhanom Ghebreyesus puts it, “We must use antibiotics responsibly, and make sure everyone has access to the right medicines, quality-assured diagnostics, and vaccines.”
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Health with BSBS Web ReportsHealth Ministryhealth newsWorld Health OrganizationAntibiotic resistance

First Published: Oct 14 2025 | 12:07 PM IST

Next Story